Angelo Paradiso

20.8k total citations
336 papers, 7.8k citations indexed

About

Angelo Paradiso is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Angelo Paradiso has authored 336 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Molecular Biology, 137 papers in Oncology and 93 papers in Cancer Research. Recurrent topics in Angelo Paradiso's work include BRCA gene mutations in cancer (42 papers), Breast Cancer Treatment Studies (41 papers) and HER2/EGFR in Cancer Research (34 papers). Angelo Paradiso is often cited by papers focused on BRCA gene mutations in cancer (42 papers), Breast Cancer Treatment Studies (41 papers) and HER2/EGFR in Cancer Research (34 papers). Angelo Paradiso collaborates with scholars based in Italy, United States and China. Angelo Paradiso's co-authors include Stefania Tommasi, Amalia Azzariti, Anita Mangia, Stephan J. Reshkin, Francesco Schittulli, Antonia Bellizzi, Letizia Porcelli, Giovanni de Simone, Antonella Daniele and Rosa Divella and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Angelo Paradiso

333 papers receiving 7.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Paradiso Italy 45 3.9k 2.9k 2.0k 1.0k 914 336 7.8k
Johan Lundin Finland 48 2.6k 0.7× 2.8k 1.0× 1.6k 0.8× 1.0k 1.0× 915 1.0× 160 7.5k
Robert Zeillinger Austria 52 4.7k 1.2× 3.7k 1.3× 3.1k 1.5× 827 0.8× 1.1k 1.2× 284 9.3k
Tim Beißbarth Germany 46 5.0k 1.3× 3.3k 1.1× 1.8k 0.9× 1.1k 1.1× 601 0.7× 227 10.3k
Mark A. Watson United States 48 3.4k 0.9× 1.9k 0.6× 1.7k 0.9× 1.4k 1.4× 794 0.9× 129 7.2k
Nicolás André France 50 4.1k 1.1× 2.8k 0.9× 1.8k 0.9× 1.2k 1.2× 434 0.5× 264 8.6k
Zhi‐Ming Shao China 50 3.9k 1.0× 3.6k 1.2× 3.0k 1.5× 1.3k 1.3× 1.1k 1.2× 222 8.6k
Hani Gabra United Kingdom 44 3.2k 0.8× 2.4k 0.8× 1.4k 0.7× 696 0.7× 986 1.1× 174 7.4k
Andrew M. Hanby United Kingdom 49 3.3k 0.9× 2.6k 0.9× 2.2k 1.1× 669 0.6× 931 1.0× 128 7.5k
David Chang United States 38 5.5k 1.4× 3.1k 1.0× 1.2k 0.6× 1.1k 1.0× 761 0.8× 84 9.6k
Anne‐Marie Mes‐Masson Canada 50 4.4k 1.1× 2.7k 0.9× 1.9k 1.0× 1.2k 1.1× 975 1.1× 272 9.1k

Countries citing papers authored by Angelo Paradiso

Since Specialization
Citations

This map shows the geographic impact of Angelo Paradiso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Paradiso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Paradiso more than expected).

Fields of papers citing papers by Angelo Paradiso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Paradiso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Paradiso. The network helps show where Angelo Paradiso may publish in the future.

Co-authorship network of co-authors of Angelo Paradiso

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Paradiso. A scholar is included among the top collaborators of Angelo Paradiso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Paradiso. Angelo Paradiso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palma, Giuseppe De, et al.. (2022). Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari. Cancers. 14(14). 3460–3460. 1 indexed citations
2.
Desantis, Vanessa, Antonio Giovanni Solimando, Ilaria Saltarella, et al.. (2021). MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease. Cancers. 13(15). 3650–3650. 14 indexed citations
3.
Daniele, Antonella, Attilio Guarini, Simona De Summa, et al.. (2021). Body Composition Change, Unhealthy Lifestyles and Steroid Treatment as Predictor of Metabolic Risk in Non-Hodgkin’s Lymphoma Survivors. Journal of Personalized Medicine. 11(3). 215–215. 6 indexed citations
4.
Dellino, Miriam, Erica Silvestris, Vera Loizzi, et al.. (2020). Germinal ovarian tumors in reproductive age women. Medicine. 99(39). e22146–e22146. 21 indexed citations
5.
Dellino, Miriam, et al.. (2020). Primary Vaginal Carcinoma Arising on Cystocele Mimicking Vulvar Cancer. Journal of Obstetrics and Gynaecology Canada. 42(12). 1543–1545. 17 indexed citations
6.
D’Oronzo, Stella, Erica Silvestris, Domenica Lovero, et al.. (2020). DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers. International Journal of Molecular Sciences. 21(17). 6096–6096. 3 indexed citations
7.
Silvestris, Erica, Giuseppe De Palma, Stefano Canosa, et al.. (2020). Human Ovarian Cortex biobanking: A Fascinating Resource for Fertility Preservation in Cancer. International Journal of Molecular Sciences. 21(9). 3245–3245. 19 indexed citations
8.
Bruno, Eleonora, Mara Colombo, Angelo Paradiso, et al.. (2020). BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers. Cancers. 12(12). 3584–3584. 4 indexed citations
9.
Bruno, Eleonora, Angelo Paradiso, Antonella Daniele, et al.. (2020). Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort. Clinical Breast Cancer. 21(3). e168–e176. 10 indexed citations
10.
Pinto, Rosamaria, Brunella Pilato, Laura Ottini, et al.. (2012). Different methylation and MicroRNA expression pattern in male and female familial breast cancer. Journal of Cellular Physiology. 228(6). 1264–1269. 32 indexed citations
11.
Azzariti, Amalia, Letizia Porcelli, Nicola Antonio Colabufo, et al.. (2011). MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment. European Journal of Pharmacology. 670(1). 74–84. 8 indexed citations
12.
Riegman, Peter, Maria Grazia Daidone, & Angelo Paradiso. (2011). Concluding Remarks: “Biobanking for Cancer Research: Rules and Roles,” November 2010, Bari, Italy. Biopreservation and Biobanking. 9(2). 195–196. 1 indexed citations
13.
Colabufo, Nicola Antonio, Marialessandra Contino, Francesco Berardi, et al.. (2010). A new generation of MDR modulating agents with dual activity: P-gp inhibitor and iNOS inducer agents. Toxicology in Vitro. 25(1). 222–230. 9 indexed citations
14.
Mangia, Anita, Annalisa Chiriatti, Antonia Bellizzi, et al.. (2009). Biological role of NHERF1 protein expression in breast cancer. Histopathology. 55(5). 600–608. 51 indexed citations
15.
Carpagnano, Giovanna Elisiana, Maria Pia Foschino Barbaro, Antonio Spanevello, et al.. (2007). 3p Microsatellite Signature in Exhaled Breath Condensate and Tumor Tissue of Patients with Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 177(3). 337–341. 55 indexed citations
16.
Cipollini, Giovanna, Stefania Tommasi, Angelo Paradiso, et al.. (2004). Genetic alterations in hereditary breast cancer. Annals of Oncology. 15. i7–i13. 42 indexed citations
17.
Paradiso, Angelo, Girolamo Ranieri, Nicola Silvestris, et al.. (2001). Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis. Clinical and Experimental Medicine. 1(3). 127–132. 5 indexed citations
18.
Paradiso, Angelo, G. Simone, M. De Lena, et al.. (2001). Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer. British Journal of Cancer. 84(5). 651–658. 29 indexed citations
19.
Grilli, Roberto, et al.. (1995). A shared effort toward better quality of care. The Consensus Conference on Breast Cancer Follow-up. Annals of Oncology. 6. S5–S10. 7 indexed citations
20.
Marsigliante, Santo, et al.. (1994). Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors. British Journal of Cancer. 69(3). 550–554. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johan Lundin Breakdown of academic impact, for papers by Robert Zeillinger Breakdown of academic impact, for papers by Tim Beißbarth Breakdown of academic impact, for papers by Mark A. Watson Breakdown of academic impact, for papers by Nicolás André Breakdown of academic impact, for papers by Zhi‐Ming Shao Breakdown of academic impact, for papers by Hani Gabra Breakdown of academic impact, for papers by Andrew M. Hanby Breakdown of academic impact, for papers by David Chang Breakdown of academic impact, for papers by Anne‐Marie Mes‐Masson
Rankless by CCL
2026